US Stock MarketDetailed Quotes

RAPHAEL PHARMACEUTICAL INC (RAPH)

Watchlist
  • 1.400
  • 0.0000.00%
15min DelayClose Jul 28 11:53 ET
28.25MMarket Cap-20.00P/E (TTM)

RAPHAEL PHARMACEUTICAL INC (RAPH) Income Statement

Quarterly·All
YOY yoy
Hide blank lines yoy
Currency: USD
2025/Q4
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
2023/Q4
2023/Q3
2023/Q2
2023/Q1
2022/Q4
2022/Q3
2022/Q2
2022/Q1
2021/Q4
2021/Q3
2021/Q2
2021/Q1
Total Operating Revenue
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Operating Expense
-35.53%254.00K
-21.32%251.00K
+26.51%315.00K
-22.30%425.00K
+632.43%394.00K
-56.24%319.00K
-40.57%249.00K
+112.02%547.00K
-103.91%-74.00K
-67.06%729.00K
-31.54%419.00K
+47.43%258.00K
+229.44%1.89M
+429.43%2.21M
-3.92%612.00K
-30.56%175.00K
--574.00K
--418.00K
--637.00K
--252.00K
Selling and Admin Expenses
-149.73%-91.00K
+13.38%178.00K
-22.67%174.00K
+110.12%353.00K
-33.21%183.00K
-28.31%157.00K
+78.57%225.00K
+16.67%168.00K
-73.78%274.00K
-87.20%219.00K
-76.14%126.00K
+61.80%144.00K
+198.57%1.05M
+565.76%1.71M
+114.63%528.00K
+7.23%89.00K
--350.00K
--257.00K
--246.00K
--83.00K
-General & Admin Expense
-149.73%-91.00K
+13.38%178.00K
-22.67%174.00K
+110.12%353.00K
-33.21%183.00K
-28.31%157.00K
+78.57%225.00K
+16.67%168.00K
-73.78%274.00K
-87.20%219.00K
-76.14%126.00K
+61.80%144.00K
+198.57%1.05M
+565.76%1.71M
+114.63%528.00K
+7.23%89.00K
--350.00K
--257.00K
--246.00K
--83.00K
Research & Development
+63.51%345.00K
-54.94%73.00K
+487.50%141.00K
-81.00%72.00K
+160.63%211.00K
-68.24%162.00K
-91.81%24.00K
+232.46%379.00K
-141.13%-348.00K
+1.59%510.00K
+248.81%293.00K
+32.56%114.00K
+277.68%846.00K
+211.80%502.00K
-78.52%84.00K
-49.11%86.00K
--224.00K
--161.00K
--391.00K
--169.00K
Operating Profit
+35.53%-254.00K
+21.32%-251.00K
-26.51%-315.00K
+22.30%-425.00K
-632.43%-394.00K
+56.24%-319.00K
+40.57%-249.00K
-112.02%-547.00K
+103.91%74.00K
+67.06%-729.00K
+31.54%-419.00K
-47.43%-258.00K
-229.44%-1.89M
-429.43%-2.21M
+3.92%-612.00K
+30.56%-175.00K
---574.00K
---418.00K
---637.00K
---252.00K
Net Non-Operating Interest Income (Expense)
-142.86%-3.00K
+42.86%-4.00K
-800.00%-7.00K
-33.33%-4.00K
--7.00K
-275.00%-7.00K
-50.00%1.00K
+50.00%-3.00K
----
+109.52%4.00K
+113.33%2.00K
+40.00%-6.00K
+75.00%14.00K
-2200.00%-42.00K
-200.00%-15.00K
-233.33%-10.00K
--8.00K
--2.00K
---5.00K
---3.00K
Non-Operating Interest Income
----
----
----
----
----
----
--1.00K
----
----
----
----
----
----
----
----
----
----
----
----
----
Non-Operating Interest Expense
----
----
--7.00K
+33.33%4.00K
----
----
----
--3.00K
----
----
----
----
----
----
----
+233.33%10.00K
----
----
--5.00K
--3.00K
Total Other Finance Costs
-100.00%-14.00K
-42.86%4.00K
----
----
---7.00K
+275.00%7.00K
+50.00%-1.00K
-50.00%3.00K
----
-109.52%-4.00K
-113.33%-2.00K
--6.00K
-75.00%-14.00K
+2200.00%42.00K
--15.00K
----
---8.00K
---2.00K
----
----
Pretax Profit
+30.89%-273.00K
+21.78%-255.00K
-29.84%-322.00K
+22.00%-429.00K
-737.10%-395.00K
+55.03%-326.00K
+40.53%-248.00K
-108.33%-550.00K
+103.24%62.00K
+67.85%-725.00K
+33.49%-417.00K
-42.70%-264.00K
-238.34%-1.92M
-442.07%-2.26M
+2.34%-627.00K
+27.45%-185.00K
---566.00K
---416.00K
---642.00K
---255.00K
Net Profit
+30.89%-273.00K
+21.78%-255.00K
-29.84%-322.00K
+22.00%-429.00K
-737.10%-395.00K
+55.03%-326.00K
+40.53%-248.00K
-108.33%-550.00K
+103.24%62.00K
+67.85%-725.00K
+33.49%-417.00K
-42.70%-264.00K
-238.34%-1.92M
-442.07%-2.26M
+2.34%-627.00K
+27.45%-185.00K
---566.00K
---416.00K
---642.00K
---255.00K
Profit from Continuing Operations
+30.89%-273.00K
+21.78%-255.00K
-29.84%-322.00K
+22.00%-429.00K
-737.10%-395.00K
+55.03%-326.00K
+40.53%-248.00K
-108.33%-550.00K
+103.24%62.00K
+67.85%-725.00K
+33.49%-417.00K
-42.70%-264.00K
-238.34%-1.92M
-442.07%-2.26M
+2.34%-627.00K
+27.45%-185.00K
---566.00K
---416.00K
---642.00K
---255.00K
Net Income to Parent Company
+30.89%-273.00K
+21.78%-255.00K
-29.84%-322.00K
+22.00%-429.00K
-737.10%-395.00K
+55.03%-326.00K
+40.53%-248.00K
-108.33%-550.00K
+103.24%62.00K
+67.85%-725.00K
+33.49%-417.00K
-42.70%-264.00K
-238.34%-1.92M
-442.07%-2.26M
+2.34%-627.00K
+27.45%-185.00K
---566.00K
---416.00K
---642.00K
---255.00K
Net Income to Common Stockholders
+30.89%-273.00K
+21.78%-255.00K
-29.84%-322.00K
+22.00%-429.00K
-737.10%-395.00K
+55.03%-326.00K
+40.53%-248.00K
-108.33%-550.00K
+103.24%62.00K
+67.85%-725.00K
+33.49%-417.00K
-42.70%-264.00K
-238.34%-1.92M
-442.07%-2.26M
+2.34%-627.00K
+27.45%-185.00K
---566.00K
---416.00K
---642.00K
---255.00K
Basic EPS
+0.00%-0.02
+0.00%-0.01
-100.00%-0.02
+33.33%-0.02
-300.00%-0.02
+75.00%-0.01
+66.67%-0.01
-50.00%-0.03
+107.69%0.01
+75.00%-0.04
+25.91%-0.03
-67.39%-0.02
-255.64%-0.13
-495.55%-0.16
+2.34%-0.04
+27.45%-0.01
---0.04
---0.03
---0.04
---0.02
Diluted EPS
+0.00%-0.02
+0.00%-0.01
-100.00%-0.02
+33.33%-0.02
-300.00%-0.02
+75.00%-0.01
+66.67%-0.01
-50.00%-0.03
+107.69%0.01
+75.00%-0.04
+25.91%-0.03
-67.39%-0.02
-255.64%-0.13
-495.55%-0.16
+2.34%-0.04
+27.45%-0.01
---0.04
---0.03
---0.04
---0.02
Deadline
Dec 31, 2025
Sep 30, 2025
Jun 30, 2025
Mar 31, 2025
Dec 31, 2024
Sep 30, 2024
Jun 30, 2024
Mar 31, 2024
Dec 31, 2023
Sep 30, 2023
Jun 30, 2023
Mar 31, 2023
Dec 31, 2022
Sep 30, 2022
Jun 30, 2022
Mar 31, 2022
Dec 31, 2021
Sep 30, 2021
Jun 30, 2021
Mar 31, 2021
Accounting Standard
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
2025/Q42025/Q32025/Q22025/Q12024/Q42024/Q32024/Q22024/Q12023/Q42023/Q32023/Q22023/Q12022/Q42022/Q32022/Q22022/Q12021/Q42021/Q32021/Q22021/Q1
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Ahead of the market open, US Treasury Secretary Bessent indicated that the United States and Iran are poised to reach an agreement the follo Show More